About This 510(k) Submission
K250150 is an FDA 510(k) clearance for the VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood cardioplegia set); VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood cardioplegia set with shunt); VANGUARD Blood cardioplegia Systems (Vanguard 4:1 Blood Cardioplegia Set Mini), a Heat-exchanger, Cardiopulmonary Bypass (Class II — Special Controls, product code DTR), submitted by Sorin Group Italia S.R.L. (Mirandola (Modena), IT). The FDA issued a Cleared decision on May 30, 2025, 129 days after receiving the submission on January 21, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.4240.